Highlights –
- South Korea’s first potential vaccine is ready for clinical testing.
- Biotech firm Genexine has developed the potential vaccine.
- GX-19 is the name of the vaccine.
- The firm will apply for clinical testing of GX-19 within May.
South Korean biotech firm Genexine’s COVID-19 deoxyribonucleic acid vaccine pipeline GX-19 is ready for c....
Tags : SOUTH KOREA, COVID-19, BIOTECH FIRM, GENEXINE, BINEX, VACCINE, GX-19,
comments (0)